Roche CE marks and launches cobas c 311
This article was originally published in Clinica
Roche Diagnostics has CE marked its cobas c 311 analyser for sale in Europe. It has launched the device in the EMEA region (Europe, the Middle East and South Africa), and Asian and Latin American markets. Basel, Switzerland-based Roche told Clinica that the instrument is cleared by the US FDA, but it is awaiting clearance of all the reagents. The analyser, which can carry out up to 300 tests per hour, is designed for small- and mid-volume labs. The cobas c 311 has a menu of over 100 assays and up to 45 can be performed simultaneously.